This content is not available in your region

Takeda gets China's approval for $62 billion Shire purchase

Access to the comments Comments
Takeda gets China's approval for $62 billion Shire purchase
Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon   -   Copyright  Kim Kyung Hoon(Reuters)
Text size Aa Aa

(Reuters) – Japan’s Takeda Pharmaceutical Co Ltd <4502.T> said on Friday China’s market regulator had approved its $62 billion (47 billion pounds) acquisition of Shire Plc <SHP.L>, bringing it closer to becoming a global top 10 drugmaker.

The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the United States and Brazil.

(Reporting by Shashwat Awasthi in Bengaluru; Editing by Sai Sachin Ravikumar)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.